Abstract

Congenital heart disease (CHD) is the most common life-threatening congenital anomaly. CHD occurs due to defects in cardiovascular development, and the majority of CHDs are caused by a multifactorial inheritance mechanism, which refers to the interaction between genetic and environmental factors. During embryogenesis, the cardiovascular system is derived from at least four distinct cell lineages: the first heart field, second heart field, cardiac neural crest, and proepicardial organ. Understanding the genes involved in each lineage is essential to uncover the genomic architecture of CHD. Therefore, we provide an overview of recent research progress using animal models and mutation analyses to better understand the molecular mechanisms and pathways linking cardiovascular development and CHD. For example, we highlight our recent work on genes encoding three isoforms of inositol 1,4,5-trisphosphate receptors (IP3R1, 2, and 3) that regulate various vital and developmental processes, which have genetic redundancy during cardiovascular development. Specifically, IP3R1 and 2 have redundant roles in the atrioventricular cushion derived from the first heart field lineage, whereas IP3R1 and 3 exhibit redundancy in the right ventricle and the outflow tract derived from the second heart field lineage, respectively. Moreover, 22q11.2 deletion syndrome (22q11DS) is highly associated with CHD involving the outflow tract, characterized by defects of the cardiac neural crest lineage. However, our studies have shown that TBX1, a major genetic determinant of 22q11DS, was not expressed in the cardiac neural crest but rather in the second heart field, suggesting the importance of the cellular interaction between the cardiac neural crest and the second heart field. Comprehensive genetic analysis using the Japanese genome bank of CHD and mouse models revealed that a molecular regulatory network involving GATA6, FOXC1/2, TBX1, SEMA3C, and FGF8 was essential for reciprocal signaling between the cardiac neural crest and the second heart field during cardiovascular development. Elucidation of the genomic architecture of CHD using induced pluripotent stem cells and next-generation sequencing technology, in addition to genetically modified animal models and human mutation analyses, would facilitate the development of regenerative medicine and/or preventive medicine for CHD in the near future.

Highlights

  • Congenital heart disease (CHD) is the most common lifethreatening congenital anomaly that occurs in ∼1% of live births

  • Current knowledge in molecular embryology suggests that the cardiovascular system is derived from at least four distinct cell lineages, namely, the first heart field (FHF), second heart field (SHF), cardiac neural crest (CNC), and proepicardial organ (PEO) (Figure 1) [6,7,8,9]

  • We recently showed that persistent truncus arteriosus (PTA) in mice hypomorphic for Tbx1 might result from agenesis of the pulmonary trunk using IP3R2LacZ mice, in which a LacZ gene was genetically inserted inframe at the translation initiation site of IP3R2 locus on the mouse genome as a molecular marker [36]

Read more

Summary

INTRODUCTION

Congenital heart disease (CHD) is the most common lifethreatening congenital anomaly that occurs in ∼1% of live births. Insight gleaned from molecular genetics combined with developmental biology approaches has helped to uncover the detailed mechanisms of cardiovascular development, the genomic architecture of CHD remains largely unknown. We provide an overview of the progress that research has made till date in understanding the molecular mechanisms contributing to cardiovascular development, which in turn can provide new directions for research to uncover the inheritance of CHD and key susceptibility genes. We first provide general background into the etiology of CHD and the nature of cardiac development, highlighting our work on the role of inositol 1,4,5-trisphosphate receptors (IP3Rs) in this process. We highlight progress to date in understanding the general genetic architecture associated with CHD and the underlying regulatory mechanisms

ETIOLOGY OF CHD
DEVELOPMENTAL ORIGINS OF THE CARDIOVASCULAR SYSTEM
Transcription factors Cell signaling and adhesion proteins Structural proteins
Gene MIM
Gain Gain
TOF TOF TOF TOF
Findings
CONCLUDING REMARKS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call